contact us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.


123 Street Avenue, City Town, 99999

(123) 555-6789


You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.


Arden's Day Blog

Arden's Day is a type I diabetes care giver blog written by author Scott Benner. Scott has been a stay-at-home dad since 2000, he is the author of the award winning parenting memoir, 'Life Is Short, Laundry Is Eternal'. Arden's Day is an honest and transparent look at life with diabetes - since 2007.

type I diabetes, parent of type I child, diabetes Blog, OmniPod, DexCom, insulin pump, CGM, continuous glucose monitor, Arden, Arden's Day, Scott Benner, JDRF, diabetes, juvenile diabetes, daddy blog, blog, stay at home parent, DOC, twitter, Facebook, @ardensday, 504 plan, Life Is Short, Laundry Is Eternal, Dexcom SHARE, 生命是短暂的,洗衣是永恒的, Shēngmìng shì duǎnzàn de, xǐyī shì yǒnghéng de

Filtering by Tag: Novo Nordisk

Novo Nordisk Receives FDA Approval of Tresiba® for Use in Children

Scott Benner

Novo Nordisk Receives FDA Approval of Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) for Use in Children and Adolescents With Diabetes

Tresiba® is the only long-acting insulin approved for use in people with type 1 and type 2 diabetes as young as age one

from PRNewswire

PLAINSBORO, N.J., Dec. 19, 2016 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL), a once-daily, long-acting basal insulin, to be used in children and adolescents with diabetes. Tresiba®, first approved by the FDA in September 2015, is now indicated to improve glycemic control in patients with type 1 and type 2 diabetes from the age of one through adulthood,1making it the only basal insulin approved for both type 1 and type 2 diabetes in patients as young as 1 year old. Tresiba® is a long-acting insulin that is released over time, has a 25 hour half-life and has a consistently flat and stable profile at steady state.1

"We are seeing a rise in the number of children and adolescents with diabetes in the U.S., especially those with type 2, and are proud to support these patients by offering new and effective treatment options," said Todd Hobbs, M.D., U.S. chief medical officer, Novo Nordisk.2 "It can be challenging for children with type 1 diabetes and their parents to manage blood sugar levels and keep up with multiple injections throughout an already busy day. With this approval, they now have another option of a long-acting insulin that is dosed once daily."

Novo Nordisk submitted the supplemental New Drug Application (sNDA) based on the results of the BEGIN™ Young 1 trial, a multi-national, 26-week, phase 3b, randomized, controlled, open-label, parallel-group, treat-to-target non-inferiority trial with a 26-week extension. BEGIN™ Young 1 compared the efficacy and safety of Tresiba® administered once-daily compared with Levemir® (insulin detemir [rDNA origin] injection) administered once-daily or twice daily, both in combination with insulin aspart, a mealtime insulin, in children and adolescents with type 1 diabetes aged 1 to 17. The results showed that Tresiba® in combination with insulin aspart effectively improved glycemic control. The most common adverse events were infection, hypoglycemia and hyperglycemia.3 The use of Tresiba® in patients one year of age and older with type 2 diabetes mellitus is also supported by evidence from adequate and well-controlled studies in adults with type 2 diabetes.1

Once-daily Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) is available in Novo Nordisk's latest insulin delivery device – FlexTouch® – as a 100 units/mL or 200 units/mL pen. Tresiba® U-100 FlexTouch® can deliver up to 80 units of insulin in a single injection. Tresiba® U-200 FlexTouch® can dose up to 160 units in a single injection. FlexTouch® is also the only prefilled insulin pen with no push-button extension.1

Eligible patients with commercial insurance can use the Tresiba® Instant Savings Card to reduce co-pays to as low as $15 a month for up to 24 months. Eligibility and other restrictions apply. For complete terms and conditions and any questions regarding eligibility, visit or call 1-855-834-3466.

Contest: Guess Arden's New Puppy's Name

Scott Benner

Arden has been asking for a puppy forever and today she got her wish when her Christmas present arrived at the airport. 

Arden spent the past weeks thinking of names for her new best friend, she took suggestions from family and friends, looked through baby name books, but in the end she decided on a name all on her own - and it's a diabetes centric name.

So the first person who can guess what Arden named her new puppy wins three pairs of blue circle shoe laces. The contest runs until someone gets the name correct. If more than one person guesses correctly I'll give three pairs to the first correct guess and one pair to each of the others but the contest will be shutdown twelve hours after the initial correct guess is made.

Puppy is three months old. He's a mix of French Bulldog and Boston Terrier. They call him a Faux French, he's such a cutie!

Okay, I'm exhausted from driving to the airport at four in the morning (he missed a connecting flight) so I'm going to take it easy while you try to figure out his name. Remember, it's diabetes related... good luck!

Only two rules: All guesses must be made in the comments of this post. Open to US and Canadian residents only for shipping cost reasons.

Arden named her new puppy Basal...

It's a Diabetes Shoelaces Extravaganza on Arden's Day

Scott Benner

Watch the video and then I'll explain...

So like I said in the video the cost of shipping is falling to my family, Usually we'd eat the cost but it's going to be a bit much so when I figure out how to do this... the one provision will be that anyone who wants a pair will have to pay the shipping costs - I'll know how much that will be next week.

Here's the next part. On Monday I'll be speaking with some people from Novo and I'm going to try to get them to see how popular the Novo #LaceUp4Diabetes laces are in the diabetes community. My hope is to talk them into making them available on a much larger scale in the future. With that in mind, it would be a huge help if you took a moment to let Novo know, here in the comments, how much you want the laces! 

A huge thank you to Novo Nordisk, my wife Kelly and the great people she works with for giving up their laces for the DOC!

Giveaway! Blue Circle Shoelaces and Signed Books

Scott Benner

What do you say we honor Diabetes Awareness Month by giving away some fresh diabetes swag?!

the giveaway items

Five pairs of those swanky blue circle shoelaces that you see all of the cool diabetes advocates wearing – courtesy of Novo Nordisk.

One signed copy of my book, Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad

One signed copy of Moira McCarthy's book, Raising Teens with Diabetes

how to enter

Complete as many entry options as you want using the Rafflecopter app below, each option gives you a different number of chances to win and some options can be performed daily.

choosing winners and other stuff you should know

Giveaway is only open to folks with US and Canadian addresses (I'm paying for shipping). Contest ends 11/30/2014 at midnight EST. Winners will be drawn at random by the Rafflecopter app. One prize per household.

Happy Diabetes Awareness Month!

Weekend Roundup

Scott Benner

Happy Blue Friday, I hope you enjoy the weekend and a few of these initiatives, stories and a giveaway.

AD_Line Break2.jpg

You take the quiz and a diabetes charity that we all love gets money - nice!


When you take this two minute quiz Novo Nordisk will make a donation to the Diabetes Hands Foundation.

Help Strip Safely to effect real change in the FDA's meter rules.


from strip safely: "FDA has two draft guidance documents about blood glucose meters that are open for comment until April 7, 2014. A “draft guidance” is basically a preview of what standards the FDA is considering requiring in order for blood glucose meters to be cleared — the law requires that FDA open its draft guidance documents up for comment before publishing a final version. FDA welcomes comments from the public, and so we highly encourage everyone affected by diabetes to submit their considered thoughts." - I did it last night, it's easy and important. Go take a look.

This week on Arden's Day


We are giving away a pair of diabetes circles shoelaces - easy to enter

This simple pancake recipe is easy on Arden's BGs

Does your DexCom make you sing?

I wrote a piece for Disney about spousal engagement and your child's diabetes management